Media Summary: Timely, effective development of therapeutic proteins and nanoparticles requires comprehensive ALiS: Automated & High-Throughput Screening for LNP Formulations Recorded 02 May 2023. Claudia Draxl of Humboldt-Universität presents "

High Throughput Analytics For Formulation - Detailed Analysis & Overview

Timely, effective development of therapeutic proteins and nanoparticles requires comprehensive ALiS: Automated & High-Throughput Screening for LNP Formulations Recorded 02 May 2023. Claudia Draxl of Humboldt-Universität presents " Thermal stability is a leading indicator of overall clinical success of biologic drug products, and DSC (differential scanning ... Presented by Jeremy Springall PhD, Scientist II, This episode delves into the crucial role of

Presented by Sachin Dubey, Ph.D., Head of Don't let your R&D timelines be jeopardized by time consuming processes. Learn how

Photo Gallery

High throughput Analytics for Formulation and Process Development of Bio  and Nano therapeutics
ALiS: Automated & High-Throughput Screening for LNP Formulations
Claudia Draxl - High-throughput spectroscopy & material discovery by beyond-DFT work & data-analysis
Leveraging High Throughput Formulation Screening with Scalable Processing
Accessible high-throughput experimentation: From startup to scale  | Research Arc
Robotic Reaction Preparation for High-Throughput Experimentation (HTE)
Accelerate Your Research with High-Throughput DSC: Introducing the Rapid Screening DSC
High-Throughput Revolutionizes Dow Chemical's R&D
DESIGN OF EXPERIMENTS (DOE) FOR DEVELOPMENT OF HIGH THROUGHPUT,  FOR ASSESSMENT OF PRODUCT QUALITY
99 - Analytical Methods in Formulation Testing (S7E9)
CHALLENGES OF HIGH CONCENTRATION PROTEIN FORMULATIONS DEVELOPMENT MOVING TO HIGH POTENT BISPECIFICS
Freeslate | A Case Study for an API Using High Throughput Experimentation
View Detailed Profile
High throughput Analytics for Formulation and Process Development of Bio  and Nano therapeutics

High throughput Analytics for Formulation and Process Development of Bio and Nano therapeutics

Timely, effective development of therapeutic proteins and nanoparticles requires comprehensive

ALiS: Automated & High-Throughput Screening for LNP Formulations

ALiS: Automated & High-Throughput Screening for LNP Formulations

ALiS: Automated & High-Throughput Screening for LNP Formulations

Claudia Draxl - High-throughput spectroscopy & material discovery by beyond-DFT work & data-analysis

Claudia Draxl - High-throughput spectroscopy & material discovery by beyond-DFT work & data-analysis

Recorded 02 May 2023. Claudia Draxl of Humboldt-Universität presents "

Leveraging High Throughput Formulation Screening with Scalable Processing

Leveraging High Throughput Formulation Screening with Scalable Processing

Leveraging

Accessible high-throughput experimentation: From startup to scale  | Research Arc

Accessible high-throughput experimentation: From startup to scale | Research Arc

High

Robotic Reaction Preparation for High-Throughput Experimentation (HTE)

Robotic Reaction Preparation for High-Throughput Experimentation (HTE)

High

Accelerate Your Research with High-Throughput DSC: Introducing the Rapid Screening DSC

Accelerate Your Research with High-Throughput DSC: Introducing the Rapid Screening DSC

Thermal stability is a leading indicator of overall clinical success of biologic drug products, and DSC (differential scanning ...

High-Throughput Revolutionizes Dow Chemical's R&D

High-Throughput Revolutionizes Dow Chemical's R&D

High

DESIGN OF EXPERIMENTS (DOE) FOR DEVELOPMENT OF HIGH THROUGHPUT,  FOR ASSESSMENT OF PRODUCT QUALITY

DESIGN OF EXPERIMENTS (DOE) FOR DEVELOPMENT OF HIGH THROUGHPUT, FOR ASSESSMENT OF PRODUCT QUALITY

Presented by Jeremy Springall PhD, Scientist II,

99 - Analytical Methods in Formulation Testing (S7E9)

99 - Analytical Methods in Formulation Testing (S7E9)

This episode delves into the crucial role of

CHALLENGES OF HIGH CONCENTRATION PROTEIN FORMULATIONS DEVELOPMENT MOVING TO HIGH POTENT BISPECIFICS

CHALLENGES OF HIGH CONCENTRATION PROTEIN FORMULATIONS DEVELOPMENT MOVING TO HIGH POTENT BISPECIFICS

Presented by Sachin Dubey, Ph.D., Head of

Freeslate | A Case Study for an API Using High Throughput Experimentation

Freeslate | A Case Study for an API Using High Throughput Experimentation

Don't let your R&D timelines be jeopardized by time consuming processes. Learn how

Optimization tools for drug formulation and discovery

Optimization tools for drug formulation and discovery

Finding the ideal